GLP-1s were just the door. Peptides are the whole room

August 5, 2026 | 10:00 AM – 1:00 PM ET

GLP-1s showed how fast demand for a peptide can burn through the legal supply. Now consumers want other compounds that boosters claim have wellness benefits. But most are only available through the black market. What now?

An FDA advisory committee is weighing whether several of these peptides should be cleared for legal sale. The outcome could pull demand back into regulated channels. Underneath it is a supply question: Who would then legally make these drugs, and what happens to the black market?

At Manufacturing Day, we'll take a look at how compounding pharmacies are thinking about demand, and what a policy shift would mean for legitimate supply.

Where do peptides go next? Get your spot.

REGISTER NOW